The Global Network works in partnership with other global health initiatives to integrate the distribution of NTD drugs with other interventions, such as immunizations, delivery of micronutrients, bednet distribution, and maternal and child health programs whenever possible. We also work to increase funding at a macro-level and engage potential partners and donors to leverage work underway to bring NTD programs to scale, produce evidence of sustainable impact, and change the landscape of poverty forever.

NTDs have been disabling, disfiguring, and blinding their victims for centuries. Although medically diverse, these diseases thrive in conditions of poverty and are particularly prevalent in remote rural areas, urban slums and conflict zones. NTDs disable on a large scale; more than 1.4 billion people who live on less than $1.25 a day suffer from one or more of these diseases. These chronic conditions also kill more than 500,000 people a year.

Several highly cost-effective, proven interventions have been developed to treat the seven most common NTDs, which account for 90% of the global NTD burden. For approximately 50 cents per person per year, we can prevent and treat these diseases – making the elimination of NTDs a best buy in public health.

The Global Network collaborates closely with the World Health Organization and other technical agencies, NGOs, donors, and the broader public health community to advocate for and implement NTD control and elimination programs.

The Global Network's Founding Collaborators include:

• The Earth Institute, Columbia University


• Liverpool School of Tropical Medicine


• Helen Keller International


• International Trachoma Initiative


• Schistosomiasis Control Initiative


• The Task Force for Global Health